Boston Scientific
BSX
BSX
1,213 hedge funds and large institutions have $90.4B invested in Boston Scientific in 2024 Q1 according to their latest regulatory filings, with 153 funds opening new positions, 443 increasing their positions, 444 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% less repeat investments, than reductions
Existing positions increased: 443 | Existing positions reduced: 444
3% less call options, than puts
Call options by funds: $468M | Put options by funds: $482M
2.25% less ownership
Funds ownership: 92.31% → 90.06% (-2.2%)
Holders
1,213
Holding in Top 10
27
Calls
$468M
Puts
$482M
Top Buyers
| 1 | +$969M | |
| 2 | +$451M | |
| 3 | +$252M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$195M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$183M |
Top Sellers
| 1 | -$1.34B | |
| 2 | -$724M | |
| 3 | -$390M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$216M |
| 5 |
Amundi
Paris,
France
|
-$176M |